Sponsor Pipeline

Jiyan Liu Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-30 NCT07518979
EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant…		 Recruitment opened
Active Trials by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07518979 EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant… Penile Cancer Recruiting
Phase 1
NCT07054307 MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or… Penile Cancer Recruiting
NCT07051187 A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis… Chronic Hepatitis B Virus (Hbv) Recruiting
Get alerts when Jiyan Liu's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free